TherapeuticsMD, Inc. Debt Conversion, Converted Instrument, Amount
TherapeuticsMD, Inc. (TXMD) reported Debt Conversion, Converted Instrument, Amount of $1.05 million for the 12-month period ending 2012-12-31, per its 10-K filed 2015-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2015-03-12
- TherapeuticsMD, Inc. debt conversion, converted instrument, amount for the quarter ending 2012-12-31 was -$1.00.
- TherapeuticsMD, Inc. debt conversion, converted instrument, amount for the quarter ending 2012-09-30 was $0.00.
- TherapeuticsMD, Inc. debt conversion, converted instrument, amount for fiscal 2012 was $1.05M, a 87.20% decline from fiscal 2011.
- TherapeuticsMD, Inc. debt conversion, converted instrument, amount for fiscal 2011 was $8.24M.
| Period end | Debt Conversion, Converted Instrument, Amount 3 month | Debt Conversion, Converted Instrument, Amount 6 month | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month |
|---|---|---|---|---|
| 2012-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$1.00 derived: sum of 2 quarters · filed 2015-03-12 | $1.05M 10-K · filed 2015-03-12 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $1.05M 10-Q · filed 2013-11-05 | ||
| 2012-06-30 | $1.05M 10-Q · filed 2013-08-07 | |||
| 2011-12-31 | $8.24M 10-K · filed 2014-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |